Posted in | News

IFC Application Hotspot from Fluidigm Now Available to Download

The Summer 2010 edition of the popular e-newsletter - IFC Application Hotspot from Fluidigm Corporation is now available free to download from http://www.fluidigm.com/newsletters/2010edition1_v5/2010edition1_v5.html.

Dedicated to advances in single-cell research the Summer 2010 issue of IFC Application Hotspot includes two pioneering customer application studies, a recorded video interview with the Genome Insitute of Singapore and a new single-cell gene expression protocol.

The first application study reports on how resolution of cell fate decisions can be revealed by single-cell gene expression analysis from zygote to blastocyst. Using Dynamic Array™ Integrated Fluidic Circuits (IFCs), and the mouse preimplantation embryo as a model, scientists from Genome Institute of Singapore applied single-cell analysis to study the expression dynamics of 48 genes across mutliple developmental time points. The described work illustrates the power of single-cell expression analysis to provide insight into developmental mechanisms.

The second application study describes how using Dynamic Array™ IFCs, scientists at Keio University analysed the expression of various cadherin genes in long-term hematopoietic stem cells (HSCs) and subpopulations of the HSCs isolated from the endosteum to better understand cadherin function as it relates to HSC-niche interactions.

Dr Paul Robson, of the Genome Institute of Singapore, discusses in a video interview, his latest research on single-cell expression data which is crucial for a detailed molecular understanding of mammalian development from fertilization to embryo implantation. His research has direct impact on clinical applications in the areas of regenerative medicine and assisted reproduction.

IFC Application Hotspot is your quick source for the latest news on how integrated fluidic circuits (IFCs) are enabling ground breaking advances in life science research. In each edition - Fluidigm report upon new products, applications innovations, and customer advances using revolutionary IFC technology.

Fluidigm develops, manufactures and markets proprietary Integrated Fluidic Circuit (IFC) systems that significantly improve productivity in life science research. Fluidigm's IFCs enable the simultaneous performance of thousands of sophisticated biochemical measurements in extremely minute volumes. These "integrated circuits for biology" are made possible by miniaturising and integrating liquid handling components on a single microfluidic device. Fluidigm's systems, consisting of instrumentation, software and single-use chips, increase throughput, decrease costs and enhance sensitivity compared to conventional laboratory systems.

For more information a recorded webinar 'Fluidigm Single-Cell Gene Expression Profiling (www.fluidigm.com/pr/single-cell-webinar.html) allows you to listen to researchers describing their latest stem and cancer cell findings using Fluidigm IFC technology.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Standard BioTools. (2019, February 13). IFC Application Hotspot from Fluidigm Now Available to Download. AZoNano. Retrieved on November 21, 2024 from https://www.azonano.com/news.aspx?newsID=18417.

  • MLA

    Standard BioTools. "IFC Application Hotspot from Fluidigm Now Available to Download". AZoNano. 21 November 2024. <https://www.azonano.com/news.aspx?newsID=18417>.

  • Chicago

    Standard BioTools. "IFC Application Hotspot from Fluidigm Now Available to Download". AZoNano. https://www.azonano.com/news.aspx?newsID=18417. (accessed November 21, 2024).

  • Harvard

    Standard BioTools. 2019. IFC Application Hotspot from Fluidigm Now Available to Download. AZoNano, viewed 21 November 2024, https://www.azonano.com/news.aspx?newsID=18417.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.